Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for LANSOPRAZOLE
- Fourteen-Day Vonoprazan-Based Dual Therapy With Amoxicillin as First-Line Helicobacter Pylori Treatment in Comparison With Extended Sequential Therapy
- Efficacy of PERT for PEI in Unresectable Pancreatic Cancer.
- A "Screen and Treat" Helicobacter Pylori Eradication Trial in Adolescents in Three Regions of Chile
- Recurrence Rate Comparison Between Esomeprazole and Lansoprazole in Eradicating Helicobacter Pylori Infection Among Children
- The Efficacy and Safty of Proton Pump Inhibitor (Lansoprazole)
- PPI Infusion Versus Oral Acid Pump Inhibitors for Bleeding Peptic Ulcers
- Effect of Kunamin in SARS-CoV-2 RT-PCR Positive Covid-19 Patients
- Study to Confirm the Safety and Efficacy of Tegoprazan in Patients With Healed Erosive Reflux Disease
- Nitazoxanide and Lansoprazole Based Regimens for H. Pylori Management
- A Study in Patients With Erosive Esophagitis to Investigate Safety, Tolerability, and Healing Rates After 4 Weeks Treatment of X842 or Lansoprazole and Symptom Pattern During Subsequent 4 Weeks Treatment With Lansoprazole
- A Study to Evaluate the Safety, Tolerability and Pharmacokinetics/Pharmacodynamics of Oral Doses of H008
- Efficacy and Safety of LXI-15028 Comparing With Lansoprazole in the Treatment of Duodenal Ulcer
- Treating People With Idiopathic Pulmonary Fibrosis With the Addition of Lansoprazole
- The Possible Efficacy and Safety of Lansoprazole Co-administration With Neoadjuvant Chemotherapy in Women With Breast Cancer
- Study to Evaluate the Safety, Efficacy of Tegoprazan for the Prevention of PUD in Patients on Treatment With NSAIDs
- Study to Evaluate the Efficacy and Safety of DWP14012 in Prevention of NSAIDs Induced Peptic Ulcer
- Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Vonoprazan and Lansoprazole in Healthy Participants
- Comparison of Vonoprazan-based Versus Lansoprazole-based Triple Therapy, High Dose Dual Therapy, Bismuth and Non-bismuth Quadruple Therapy in the First-line Treatment of Helicobacter Pylori Infection
- Efficacy of Tegoprazan Based Bismuth Quadruple Therapy for Helicobacter Pylori Infection
- Response to Oral Lansoprazole of Inorganic Pyrophosphate Levels in Patients With Grönblad-Stranberg Disease (Pseudoxanthoma Elasticum)
- Study to Evaluate the Safety and Efficacy of X842 in Patients With Reflux Esophagitis
- A Study to Assess the Effects of Acid-Reducing Agent(s) on JNJ-64417184 in Healthy Participants
- PPI Therapy Impact on GERD After Sleeve Gastrectomy
- Study to Evaluate the Efficacy and Safety of DWP14012 on Maintaining Healing in Subjects With Healed Erosive Esophagitis
- A Proof of Concept Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast Cancer
- Study to Investigate the Use of Acalabrutinib in the Treatment of Patients With Chronic Lymphocytic Leukemia
- Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Helicobacter Pylori Infection
- Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Erosive Esophagitis
- Effectiveness of Vonoprazan vs Omeprazole as Empiric Therapy for Gastroesophageal Reflux Disease (GERD) Patients Without Alarm Features
- Study to Confirm the Safety and Efficacy of Tegoprazan in Patients With Healed Erosive Esophagitis
- Dexlansoprazole MR-Based Concomitant Quadruple Therapy
- A Proof of Concept, Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast Cancer
- AZD4635 Relative Bioavailability Study
- Prevention of Recurrent Ulcer Bleeding in Patients With Idiopathic Gastroduodenal Ulcer
- Triple Therapy With Tegoprazan in H. Pylori Positive Patients
- PK-PD Comparative Study of Lansoprazole Capsules and Lansoprazole Enteric-coated Capsules in Healthy Chinese Volunteers
- Pharmacokinetic Study of Lansoprazole Capsules in Healthy Chinese Volunteer
- Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of After Administrations of DWP14012 Alone and Combinations of DWP14012, Clarithromycin and Amoxicillin in Healthy Male Subjects
- A Crossover Study to Assess the Drug-drug Interaction of Acid Reducing Agent(s) on the Pharmacokinetics of a Single Oral Dose of Lumicitabine (JNJ-64041575) in Healthy Adult Participants
- Comparison of the Efficiency of Two Different PPI Formula in Atypical GERD
- Cardiac Safety of Lansoprazole and Domperidon Combination
- A Phase 3 Study to Evaluate the Efficacy and Safety of Triple Therapy With CJ-12420 in H. Pylori Positive Patients
- Study of Pembrolizumab, Radiation and Immune Modulatory Cocktail in Cervical/Uterine Cancer
- Intraluminal Therapy for Helicobacter Pylori Infection
- Drug Interaction With Proton Pump Inhibitors for Nifedipine ER Tablets
- An Open-Label Trial of Dexlansoprazole 60mg for the Relief of Heartburn During the Fasting Month of Ramadan
- Study to Assess the Relative Bioavailability of Fixed-Dose Combination (FDC) Tablet (Simeprevir, Odalasvir and AL-335) Compared With Single Agents Administered Together, and to Assess the Effect of Multiple-Dose Lansoprazole or Omeprazole on Single-
- Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Duodenal Ulcer Participants With or Without Helicobacter Pylori Infection
- Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Gastric Ulcer Participants With or Without Helicobacter Pylori Infection
- Genotype-tailored Treatment of Symptomatic Acid-Reflux in Children With Uncontrolled Asthma
- The Efficacy of Lansoprazole and Domperidone Combination on Intragastric and Intraesophageal Acidity
- Efficacy and Saafety of Omez Iin Patients With H.Pylori Associated Diseases
- TAK-438 Bismuth Drug Interaction Study
- Efficacy and Safety of Dexlansoprazole in Healing and Maintaining Healing of Erosive Esophagitis
- Confocal Endomicroscopy for Non-Erosive Reflux Disease Detection
- Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Gastric Ulcer
- Treatment Effect Between Dexlansoprazole and Double-dose Lansoprazole in Obesity Patients With Reflux Esophagitis
- A Study to Evaluate REbamiPide as an Adjuvant Regimen to Heal erosIve Reflux Esophagitis
- Triple Therapy Versus Levofloxacin-based Therapy for Helicobacter Pylori Eradication in Mexico.
- Comparison of Daily Single Dose Triple and Conventional Triple Therapies for Helicobacter Pylori Infection
- Prophylaxis for Aspiration of Gastric Contents.
- Vonoprazan Study in Patients With Erosive Esophagitis to Evaluate Long-term Safety
- Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Clarithromycin Quadruple Therapy
- A Study to Evaluate the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics of TAK-117 (MLN1117) in Healthy Participants
- Proton Pump Inhibitors and Risk of Community-acquired Pneumonia
- Comparison of Dexlansoprazole-based Triple and Rabeprazole-based Triple Therapies for Helicobacter Pylori Infection
- Pain Management After Cardiac Surgery - Opioids or NSAID
- Efficacy and Safety of Vonoprazan Compared to Lansoprazole in the Maintenance Treatment of Erosive Esophagitis
- Efficacy and Safety of Oral Once-Daily Vonoprazan (TAK-438) in Participants With Erosive Esophagitis
- Impact of Pantoprazole on 24-H Glycemic Control and on Post-prandial Glucose Excursion in Patients With Type 2 Diabetes
- Open-label PK Study to Evaluate Lansoprazole and Neratinib in Healthy Subjects
- The Relationship Between Gastroesophageal Reflux and Pediatric Rhinitis: Significance of Pale/Blue Colored Turbinate
- Pharmacokinetics of Dipyridamole Administered as Aggrenox® (Dipyridamole Extended Release Plus Aspirin) Capsule Versus Dipyridamole Immediate Release Plus Aspirin Following Alteration of Stomach pH
- Efficacy of Acetylcysteine-containing Triple Therapy in the First Line of Helicobacter Pylori Infection
- High Dose Amoxicillin Versus Tetracycline as Second-line Treatment of Resistant Helicobacter Pylori Infection
- Amoxicillin/Metronidazole Based Quadruple Therapy for Helicobacter Pylori Eradication
- Takepron Intravenous 30 mg Specified Drug-use Survey [Acute Stress Ulcer and Acute Gastric Mucosal Lesions]
- Lansoprazole Intravenous 30 mg Specified Drug-use Survey [Hemostatic Effect/Rebleeding Rate]
- The Use of Proton Pump Inhibitor on the Prevention of Gastric Cancer Bleeding
- Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout
- Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal Impairment
- Long-term Use of Takepron on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs
- Long-term Use of Takepron Capsules on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin
- Effect of Proton Pump Inhibitors on Endothelial Function
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- Lansoprazole Tablets Special Drug Use Surveillance Gastroesophageal Reflux Disease With Dyspepsia Symptoms
- Lansoprazole in Preterm Infants With Gastroesophageal Reflux (GER)
- Triple Therapy Versus Quadruple Therapies in the First Line Therapy of Helicobacter Pylori Infection
- High Dose PPI Triple Therapy Versus Sequential Therapy for Helicobacter Pylori Eradication
- Rosuvastatin to Decrease Residual Immune Activation in HIV Infection
- Effects of Lansoprazole on Sitagliptin Glucose-lowering Ability in Healthy Males: a Randomised Crossover Study
- Lansoprazole in Preterm Infants With Reflux
- The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Lansoprazole for Insulin Independence Among Patients With Existing Type 1 Diabetes
- The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Omeprazole for Insulin Independence Among Recent Onset Type 1 Diabetes Patients
- A Study of LY2940680 in Healthy Participants
- Empirical Rescue Therapies of Helicobacter Pylori Infection
- Bismuth Improves the Efficacy of Levofloxacin-containing Triple Therapy for Helicobacter Pylori Treatment
- Comparison of the Efficacy of Levofloxacin-based Sequential Therapy and Triple Therapy as Second Line Therapy
- Effect of Proton Pump Inhibitor on Residual Platelet Reactivity After Clopidogrel in Homogenous Genetic Strata
- Efficacy Study of Ilaprazole to Treat Erosive Esophgitis
- Efficacy of TAK-438, Amoxicillin and Clarithromycin in the First Line Eradication of H. Pylori
- Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Maintenance Treatment of Healed Erosive Esophagitis
- Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Non-steroidal Anti-inflammatory Drug (NSAID)
- Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose Aspirin
- Efficacy and Safety of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose Aspirin
- Efficacy and Safety of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Non-steroidal Anti-inflammatory Drug (NSAID)
- Efficacy and Safety of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Duodenal Ulcer
- Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Gastric Ulcer
- Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Erosive Esophagitis
- The Frequency of Eosinophilic Esophagitis in Patients With Heartburn That is Refractory to Proton Pump Inhibitors
- Safety and Efficacy Study of Fentanyl Buccal Tablet Use in the Emergency Department for Isolated Extremity Injury
- Bioequivalence Study of Lansoprazole DR Capsules 30 mg in Fasting Conditions
- Evaluation of Methods for the Determination of Chromogranin A in Routine Blood Samples
- PPI vs H2RA in Patients With Helicobacter Pylori-Negative Idiopathic Bleeding Ulcers
- Double the Dose of Clopidogrel or Switch to Prasugrel to Antagonize Proton Pump Inhibitor Interaction.
- Combination Therapy With Sitagliptin and Lansoprazole to Restore Pancreatic Beta Cell Function in Recent-Onset Type 1 Diabetes
- Study Evaluating Effect of Esomeprazole, Omeprazole or Lansoprazole on the Pharmacodynamics (PD) and Pharmacokinetics (PK) of Clopidogrel
- Safety and Efficacy of Lansoprazole in Patients With Reflux Disease
- Efficacy and Safety Evaluation of Levofloxacin Triple Therapy for Helicobacter Pylori Eradication
- Oral vs Intravenous and Proton Pump Inhibitor (PPI）for Peptic Ulcer Bleeding (PUB)
- Study of Anti-reflux Medication as a Potential Treatment for Glue Ear in Children
- S0701, Trial of Three Antibiotic Regimens to Eradicate Helicobacter Pylori (H. Pylori)
- Lansoprazole 30 mg DR Capsule Fasting Replicate Sprinkle Study
- Lansoprazole 30 mg DR Capsule Replicate Food Study
- Lansoprazole 30 mg DR Capsule Fasting Study
- Lansoprazole for Subgroups of Functional Dyspepsia
- The Effect of Lansoprazole in Combination With Ecabet Sodium for Gastroesophageal Reflux Disease
- Proof of Concept Study Efficacy of an Antacid/Lansoprazole Combination for Relief of Heartburn
- An Efficacy Study to Compare the Treatment Effects of Rabeprazole and Lansoprazole Depending on the Genotyping of CYP2C19 in Treating Reflux Esophagitis
- Study to Compare Gastric Inhibition of Two Proton Pump Inhibitors (CL2008-18)(P07815)(COMPLETED)
- Study Evaluating The Potential Effect Of Lansoprazole On The Pharmacokinetics Of Bosutinib In Healthy Subjects
- A Study of the Effects of Multiple Doses of Dexlansoprazole, Lansoprazole, Omeprazole or Esomeprazole on the Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Participants.
- Twice Daily Prevacid for the Treatment of Laryngopharyngeal Reflux
- Peptic Ulcer Disease in Ischemic Heart Patients Taking Aspirin and Clopidogrel With or Without Proton Pump Inhibitor
- Novel Therapy to Preserve Beta Cell Function in New Onset Type 1 Diabetes
- Levofloxacin Versus Clarithromycin Triple Therapy in First-Line Treatment for Helicobacter Pylori Eradication
- Efficacy and Safety of Lansoprazole on Gastric and Duodenal Ulcers in Patients Taking Nonsteroidal Anti-Inflammatory Drugs
- A Safety and Efficacy Study of Lansoprazole in Preventing Aspirin-Induced Gastric and Duodenal Ulcers
- Role of Mosapride in Patients With Gastroesophageal Reflux Disease
- Comparison of the Efficacy for Stress Ulcer Prophylaxis Between the Patients Received Lansoprazole OD and Control Group Weaning From Mechanical Ventilator in Respiratory Care Center: a Randomized Control Trial
- Efficacy/Safety of Lansoprazole in Patients With Frequent Nighttime Heartburn
- Fentanyl Administered Intraorally for Rapid Treatment of Orthopedic Pain
- Lansoprazole Versus Mosapride for Functional Dyspepsia
- Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Comparison of the Remission Rates of Once Daily Treatment With Esomeprazole 20mg and Lansoprazole 15mg for 6 Months in Patients Whose EE Has Been Healed
- A Multicenter, Randomized, Double Blind, Double Dummy, Parallel-Group Efficacy Study Comparing 8 Weeks of Treatment With Esomeprazole Magnesium (40mg qd) to Lansoprazole (30mg qd) for the Healing of Erosive Esophagitis in Patients With Moderate or S
- Study Comparing Esomeprazole Magnesium 40mg Once Daily Versus Lansoprazole 30 mg Twice Daily in Symptom Control of Subjects With Persistent Gastrooesophageal Reflux Disease (GERD)
- Dietary Control Alone Versus Dietary Control Plus Use of Proton Pump Inhibitors to Treat Pediatric Hoarseness
- A Randomized, Open-Label, Comparative 3-Way Treatment Crossover Study of 24-Hour Intragastric pH Profile of Once Daily Oral Administration of Esomeprazole 40mg, Lansoprazole 30mg, and Pantoprazole 40mg at Steady State in NSAID-Using Patients
- Lansoprazole to Treat Children With Asthma
- A Clinical Trial of Proton Pump Inhibitors to Treat Children With Chronic Otitis Media With Effusion
- A Study of the Use of High-dose Proton Pump Inhibitor for the Treatment of Gastro-oesophageal Reflux Related Non-cardiac Chest Pain - a Randomized Double-blind Placebo-controlled Study
- The Effects of Reducing Stomach Acid on Post-tonsillectomy Pain
- Safety and Efficacy of Ilaprazole 5, 20 and 40 mg QD and Lansoprazole 30 mg QD on Healing of Erosive Esophagitis
- Pharmacokinetic Study of Lansoprazole in Cystic Fibrosis
- Do Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux Predict Response to Treatment?
- Lansoprazole to Treat Children With Asthma
- Evaluation of 24-Hour Intragastric pH Using Esomeprazole, Lansoprazole, and Pantoprazole in Hispanic Patients With GERD
- Efficacy/Safety of Lansoprazole in Patients With Frequent Heartburn
- Efficacy/Safety of Lansoprazole in Patients With Frequent Heartburn
- Safety and Efficacy of Lansoprazole 30mg Twice Daily in Treatment of Laryngitis Associated With Gastroesophageal Reflux
- Elucidation of Acid-Induced Pulmonary Inflammation
- An Open Label pH Comparison of Esomeprazole and Lansoprazole in Barrett's Esophagus Patients
- Efficacy of Lansoprazole in Chronic Post Nasal Drip
- The Use of Lansoprazole to Treat Infants With Symptoms of Gastroesophageal Reflux
- Randomized Trial for Pharmacogenomics-based Proton Pump Inhibitor Therapy in Children
- Nexium 40mg Once Daily vs Prevacid 30mg Twice a Day for Control of Severe GERD
- The Influence of FP-10 on the Eradication Rates of H. Pylori by a Triple Therapy
- Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis
- Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis
- Effect of Prevacid on Prostaglandin Levels in Patient With Stress Ulcer
- A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy.
- Study of 24-hour Intragastric pH Profiles of Esomeprazole 40 mg and Lansoprazole 30 mg in Healthy Volunteer Subjects
- Lansoprazole Preventing Gastroduodenal Stress Ulcerations
- A Study to Evaluate the Effect of Lansoprazole on Infants With Gastroesophageal Reflux Disease.
- Investigation of the Association Between Nasal Polyposis and Extraesophageal Reflux Disease
- Proton Pump Inhibitor Therapy for Mild to Moderate Obstructive Sleep Apnea
- Treatment of Zollinger-Ellison Syndrome With Prevacid
- Intravenous vs Oral Lansoprazole on Gastric Acid Secretion in Subjects With Erosive Esophagitis
- A Comparison of Safety and Treatment in Subjects With Osteoarthritis Taking Low Dose Aspirin
- A Study to Evaluate the Effect of Lansoprazole on Hospitalized Neonates With Gastroesophageal Reflux Disease
- Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pylori
Clinical trials list
click for details